Carlos V. Paya
CIK: 0001606244
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 15, 2026PCVX
Vaxcyte, Inc.
Award(A)Direct2.3K shares- - May 14, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
Award(A)Direct8.7K shares- - Jun 12, 2025PCVX
Vaxcyte, Inc.
Award(A)Direct3K shares- - May 15, 2025COLL
COLLEGIUM PHARMACEUTICAL, INC
Award(A)Direct19.6K shares- - Dec 9, 2024PCVX
Vaxcyte, Inc.
Award(A)IndirectStock Option (right to buy)
7.3K shares- - Dec 9, 2024PCVX
Vaxcyte, Inc.
Gift(G)DirectStock Option (right to buy)
7.3K shares- - Dec 6, 2024PCVX
Vaxcyte, Inc.
Gift(G)Direct2.5K shares- - Dec 6, 2024PCVX
Vaxcyte, Inc.
Award(A)Indirect2.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 | PCVX Vaxcyte, Inc. | Award(A) | 2,265 | - | $0 | Direct |
| May 14, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award(A) | 8,741 | - | $0 | Direct |
| Jun 12, 2025 | PCVX Vaxcyte, Inc. | Award(A) | 3,041 | - | - | Direct |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award(A) | 19,582 | - | - | Direct |
| Dec 9, 2024 | PCVX Vaxcyte, Inc. | Award(A) Stock Option (right to buy) | 7,250 | - | - | Indirect |
| Dec 9, 2024 | PCVX Vaxcyte, Inc. | Gift(G) Stock Option (right to buy) | 7,250 | - | - | Direct |
| Dec 6, 2024 | PCVX Vaxcyte, Inc. | Gift(G) | 2,500 | - | $0 | Direct |
| Dec 6, 2024 | PCVX Vaxcyte, Inc. | Award(A) | 2,500 | - | $0 | Indirect |
1-8 of 8 transactions
About Paya Carlos V
Paya Carlos V (SEC CIK 0001606244) files insider reports with the SEC as Director of Vaxcyte, Inc. (PCVX) and Director of COLLEGIUM PHARMACEUTICAL, INC (COLL).
Signal8 holds 6 ownership filings by Paya Carlos V (1 Form 3, 5 Form 4), filed between Dec 10, 2024 and Jun 16, 2026. Those filings report 8 transactions, from Dec 6, 2024 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Paya Carlos V's filings is in SAN CARLOS, CA.
Recent filings by Paya Carlos V
- Jun 15, 2026: Grant or award of PCVX shares (Form 4, code A).
- May 14, 2026: Grant or award of COLL shares (Form 4, code A).
- Jun 12, 2025: Grant or award of PCVX shares (Form 4, code A).
- May 15, 2025: Grant or award of COLL shares (Form 4, code A).
- Dec 9, 2024: Grant or award of PCVX derivative securities (Form 4, code A).
Other insiders filing for Vaxcyte, Inc. (PCVX)
- Wassil Jim, EVP, Chief Scientific Ofc, COO
- Cowan Elvia, SVP, Finance & CAO
- PICKERING GRANT, CHIEF EXECUTIVE OFFICER
- GUGGENHIME ANDREW, PRESIDENT AND CFO
- Dhaliwal Harpreet S., Chief Technical Ops Officer
- Jodar Luis, Chief Medical Officer